Indiana 2025 Regular Session

Indiana Senate Bill SB0506

Introduced
1/16/25  

Caption

Pharmacy employment regulations.

Impact

This bill is expected to have significant implications for pharmacy operations within the state. By formalizing work hour limits and breaks, SB 506 seeks to reduce burnout among pharmacists and ensure they are able to provide adequate patient care. Pharmacists will be empowered to take necessary breaks, which in turn could enhance patient safety and satisfaction. Through these measures, the bill promotes a healthier working environment for pharmacy staff, which may also lead to improved long-term retention rates in the profession.

Summary

Senate Bill 506 aims to amend Indiana's pharmacy employment regulations to enhance working conditions and patient care. A notable feature of this bill is the imposition of limits on the number of continuous hours a pharmacist can work, restricting shifts to no more than 13 hours, and ensuring at least 8 hours of rest between consecutive shifts. Additionally, the legislation mandates scheduled breaks for pharmacists during their shifts, thereby addressing the work-life balance of pharmacy personnel. The effective date for these regulations is set for July 1, 2025.

Contention

However, some concerns have been raised regarding the potential challenges that these regulations may pose to pharmacy operations, particularly in small or rural settings where staffing may be thin. Critics argue that the constraints on work hours might complicate the ability of pharmacies to manage patient influx, especially in emergencies. Furthermore, the provision allowing individuals to pick up prescription refills when a pharmacist is unavailable introduces considerations about ensuring that patients receive the necessary consultation regarding their medications, underlining a balance between operational efficiency and patient safety.

Companion Bills

No companion bills found.

Similar Bills

AZ HB2291

Opioids; containers; labeling; requirements; repeal

UT SB0312

Pharmacy Practice Amendments

NJ S3388

Allows pharmacists to transfer Schedule II attention-deficit/hyperactivity disorder prescriptions.

NJ A4391

Allows pharmacists to transfer Schedule II attention-deficit/hyperactivity disorder prescriptions.

TX SB683

Relating to the licensing and regulation of pharmacists and pharmacies.

TX HB2766

Relating to electronic and other controlled substance prescriptions under the Texas Controlled Substances Act; authorizing a fee.

TX HB1668

Relating to the licensing and regulation of pharmacists and pharmacies.

TX SB460

Relating to the licensing and regulation of pharmacists and pharmacies.